HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Surgery
Reference62 articles.
1. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.;Ravdin;J Clin Oncol,2001
2. Prognostic and predictive factors in breast cancer.;Bundred;Cancer Treat Rev,2001
3. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.;Fitzgibbons;Arch Pathol Lab Med,2000
4. Population-based validation of the prognostic model ADJUVANT! for early breast cancer.;Olivotto;J Clin Oncol,2005
5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.;Slamon;N Engl J Med,2001
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3–Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3–Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial;Journal of Clinical Oncology;2023-12-20
2. Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy;Current Molecular Pharmacology;2023-08-10
3. HER2-positive breast cancer: cotargeting to overcome treatment resistance;Current Opinion in Oncology;2023-07-06
4. Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer;Clinical Cancer Research;2023-04-10
5. Targeting of ErbB1, ErbB2, and their Dual Targeting Using Small Molecules and Natural Peptides: Blocking EGFR Cell Signaling Pathways in Cancer: A Mini-Review;Mini-Reviews in Medicinal Chemistry;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3